Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 11

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 11
---
FOR” the Compensation Proposal and “FOR” the Kineta Adjournment Proposal.

Your vote is very important, regardless of the number of shares of Kineta Common Stock you own. The Mergers cannot be completed unless the Merger Agreement is approved by Kineta stockholders. Assuming a quorum is present, the approval of the Merger Agreement Proposal requires the affirmative vote of a majority of the outstanding shares of Kineta Common Stock entitled to vote on the Merger Agreement Proposal.

Whether or not you plan to attend the Kineta special meeting via the Kineta special meeting website, we urge you to please promptly complete, sign, date and return the accompanying proxy card in the enclosed postage-paid envelope or authorize the individuals named on the accompanying proxy card to vote your shares by calling the toll-free telephone number or by using the Internet as described in the instructions included with the accompanying proxy card. If your shares of Kineta Common Stock are held in the name of a bank, broker, trustee or other nominee, please follow the instructions on the voting instruction card furnished by such bank, broker, trustee or other nominee.

#### By Order of the Kineta Board of Directors,

#### Craig W. Philips
President and Secretary

Dated: [●], 2025

ADDITIONAL INFORMATION Each of TuHURA and Kineta files reports, proxy statements and other information with the SEC as required by the Exchange Act. The SEC maintains a website that contains reports, proxy statements and other information about TuHURA and Kineta. Their filings are available for you free of charge to review through the SEC’s website at www.sec.gov. The reports and other information filed by TuHURA and Kineta with the SEC are also available at their respective websites: http://www.tuhurabio.com for TuHURA and http://www.kinetabio.com for Kineta. You may request copies of this joint proxy statement/prospectus and other information, without charge, by telephone or written request directed to:

| For Information Regarding TuHURA:      |     | For Information Regarding Kineta: |
| TuHURA Biosciences, Inc.               |     | Kineta, Inc.                      |
| 10500 University Center Dr., Suite 110 |     | 7683 SE 27th Street, Suite 481    |
| Tampa, Florida 33612                   |     | Mercer Island, WA 98040           |
| (813) 875-6600                         |     | (206) 378-